Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
Cheng‐Xin Gong, Chun‐Ling Dai, Fei Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Emerging Advances in Nano-biomaterial Assisted Amyloid Beta Chimeric Antigen Receptor Macrophages (CAR-M) Therapy: Reducing Plaque Burden in Alzheimer's Disease.
Nand Lal Kushwaha, Drishti Panjwani, Shruti Patel, et al.
Journal of drug targeting (2024), pp. 1-21
Closed Access | Times Cited: 2
EFMC: Trends in Medicinal Chemistry and Chemical Biology
Yves P. Auberson, Paola B. Arimondo, Maria Duca, et al.
ChemBioChem (2023) Vol. 24, Iss. 7
Open Access | Times Cited: 7
Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease
Anna Pasieka, Dawid Panek, Paula Zaręba, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 88-89, pp. 117333-117333
Open Access | Times Cited: 7
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
Chun‐Ling Dai, Fei Liu, Khalid Iqbal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15230-15230
Open Access | Times Cited: 11
Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
Oksana Fihurka, Yanhong Wang, Yuzhu Hong, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 6
Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 5
Multifunctional anti-Alzheimer's agents: Synthesis, biological evaluation, and molecular docking study of new 2-phenoxyacetamide/3-phenoxypropanamide/4-oxobutanamide derivatives
Shakila Shakila, Burcu Kılıç, Merve Bardakkaya, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139106-139106
Closed Access | Times Cited: 1
Gut Microbiota and Alzheimer's Disease: Exploring Natural Product Intervention and the Gut–Brain Axis for Therapeutic Strategies
Jajati K. Pasupalak, Prabha Rajput, Girdhari Lal Gupta
European Journal of Pharmacology (2024), pp. 177022-177022
Closed Access | Times Cited: 1
Omnidirectional improvement of mitochondrial health in Alzheimer's disease by multi-targeting engineered activated neutrophil exosomes
Lei Zhang, Jiaquan Lin, Kai Xiang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 470-487
Open Access | Times Cited: 1
Iron metabolism: An emerging therapeutic target underlying the anti-Alzheimer's disease effect of ginseng
Nan Li, Yuhan Duan, Lei Chen, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 79, pp. 127252-127252
Closed Access | Times Cited: 4
In Silico and In Vitro Studies of Benzothiazole-Isothioureas Derivatives as a Multitarget Compound for Alzheimer’s Disease
Martha Cecilia Rosales‐Hernandéz, Leticia Guadalupe Fragoso Morales, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12945-12945
Open Access | Times Cited: 7
Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide
Paulina González, Laurent Sabater, Émilie Mathieu, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1327-1327
Open Access | Times Cited: 6
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
Tim Keuler, Carina Lemke, Paul W. Elsinghorst, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1097-1108
Open Access | Times Cited: 6
Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer’s Disease
Marc S. Weinberg, Yingnan He, Pia Kivisäkk, et al.
Journal of Alzheimer s Disease (2023) Vol. 99, Iss. s2, pp. S355-S365
Closed Access | Times Cited: 3
Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer’s Disease
Dhairiya Agarwal, Sumit Kumar, Ramesh Ambatwar, et al.
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 2, pp. 219-242
Closed Access
Computational identification of potential acetylcholinesterase (AChE) and monoamine oxidase-B inhibitors from Vitis vinifera: a case study of Alzheimer’s disease (AD)
Salimat O. Sofela, Abdulwasiu Ibrahim, Uchechukwu Chibuzo Ogbodo, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access
Network-Pharmacology and Central Nervous System Drug Development
Alan Talevi
AAPS introductions in the pharmaceutical sciences (2024), pp. 213-227
Closed Access
Chromenone: An emerging scaffold in anti-Alzheimer drug discovery
Uma Agarwal, Saroj Verma, Rajiv Kumar Tonk
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 111, pp. 129912-129912
Closed Access
Three Neurodegenerative Diseases: A Single Hope
Sarah Youssef, Hadeer N. Atalah, Marwa T. Badawy, et al.
(2024), pp. 43-66
Closed Access
Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease
Svit Ferjančič Benetik, Damijan Knez, Aleš Obreza, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108748-108748
Open Access
Multitarget Neuroprotective Effects of Quercetin on the Pathogenesis of Amyloid-β1-42 in Alzheimer’s Disease: In-vitro and In-silico study
Puguh Novi Arsito, Rima Erviana, Galih Titisari Kharismawati, et al.
BIO Web of Conferences (2024) Vol. 135, pp. 01004-01004
Open Access
Structure of Full-Length Src Kinase and Its Key Phosphorylated States: Molecular Dynamics Study
Maria A. Strelkova, Anna P. Tolstova, Vladimir A. Mitkevich, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12391-12391
Open Access
Behavioral and Biochemical Effects of an Arylhydrazone Derivative of 5-Methoxyindole-2-Carboxylic Acid in a Scopolamine-Induced Model of Alzheimer’s Type Dementia in Rats
Polina Petkova‐Kirova, Neda Anastassova, Borislav Minchev, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5711-5711
Open Access
Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer’s Disease
Melvin R. Hayden, Neetu Tyagi
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1741-1741
Open Access
Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease
Elisa Uliassi, Anna Pasieka, Eleonora Diamanti, et al.
(2024), pp. 193-201
Closed Access

Scroll to top